Specialty Area
Spotlight
Topics
Institute for Value-Based Medicine
About AJMC
Podcasts
CE
Subscribe
- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Switching Therapies, Managing Adverse Effects, and Adherence Challenges
Panelists discuss how balancing adverse-effect management with adherence optimization drives effective therapy transitions.
EP: 1.Clinical and Economic Burden of Schizophrenia
EP: 2.Symptoms Associated with Schizophrenia
EP: 3.Risk Factors for Schizophrenia
EP: 4.Challenges of Early and Accurate Diagnosis in Schizophrenia
EP: 5.Exploring Schizophrenia Progression and Its Impact on Quality of Life
EP: 6.Consequences of Relapse in Schizophrenia Care
EP: 7.Addressing Social Determinants of Health and Unmet Needs in Schizophrenia
EP: 8.Current Treatment Guidelines for Schizophrenia
EP: 9.First- and Second-Generation Antipsychotic Therapies and Treatment Sequencing
Now Viewing
EP: 10.Switching Therapies, Managing Adverse Effects, and Adherence Challenges
EP: 11.Xanomeline/Trospium Mechanism of Action, Efficacy, and Safety
EP: 12.Use of Xanomeline/Trospium in Clinical Practice
EP: 13.Comparing Safety Profiles and Health Care Costs
EP: 14.Emerging Therapies in Schizophrenia
EP: 15.Addressing Access Barriers and Formulary Restrictions
EP: 16.Final Thoughts on Improving Access and Care
Panelists discuss how therapy switching is often required to optimize outcomes, especially when adverse effects compromise adherence or efficacy wanes over time.
Panelists discuss how neurologic, metabolic, and cardiovascular adverse effects demand vigilant management to prevent treatment discontinuation.
Panelists discuss how adherence remains a linchpin of success, with behavioral and digital interventions offering promising tools to support patient engagement.
Related Videos
Related Content
